Results 321 to 330 of about 126,141 (353)

Janus Kinase (JAK) Inhibitors

2022
Courtney E. Heron, Lindsay C. Strowd, Steven R. Feldman   +2 more
openaire   +1 more source

<p>JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on the Emerging Clinical Data</p>

Journal of Inflammation Research, 2020
Richard Conway
exaly  

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

Nature Reviews Clinical Oncology, 2018
Daniel E Johnson, Jennifer R Grandis
exaly  

PAN-JAK Inhibitors/Non-selective JAK Inhibitors

Salih Levent Çınar, Fatih Can Aba
openaire   +1 more source

JAK inhibitors: promising for a wider spectrum of autoimmune diseases?

Lancet, The, 2019
Maria G Tektonidou
exaly  

Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond

Nature Reviews Drug Discovery, 2011
Hagop M Kantarjian, Jorge Cortes, Srdan Verstovsek,,, of Medicine   +2 more
exaly  

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap, Johann Sebastian de Bono
exaly  

The emerging safety profile of JAK inhibitors in rheumatic disease

Nature Reviews Rheumatology, 2017
Kevin L Winthrop
exaly  

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer

Signal Transduction and Targeted Therapy, 2023
exaly  

JAK Inhibitors: Prospects in Connective Tissue Diseases

Clinical Reviews in Allergy and Immunology, 2020
Hanxiao You, Dong Xu, Jiuliang Zhao
exaly